Status:
COMPLETED
Pharmacokinetic Analysis of Nicotinamide Riboside
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
University of Copenhagen
Conditions:
Healthy Participants
Eligibility:
MALE
18-30 years
Phase:
EARLY_PHASE1
Brief Summary
Nicotinamide riboside is a newly discovered vitamin B3. The pharmacokinetics in humans is so far not analyzed.
Eligibility Criteria
Inclusion
- BMI 18-25, healthy, male,
Exclusion
- liver or kidney diseases, other diseases
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT02300740
Start Date
December 1 2014
Last Update
February 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Research Laboratories, Aarhus University Hospital
Aarhus, Denmark, 8000